ICon portfolio
ICon has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Immunai's $215M Series B+ round in October 2021, alongside Koch Disruptive Technologies, 8VC, Piedmont Capital Investments and 3 others. That company is in Health and bio.
What ICon invests in
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
- Education · 1 · 100%
How ICon invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $215M |
ICon portfolio companies
| Company | Round with ICon | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $215M | $295M | Oct 28, 2021 Series B+ |
Most frequent co-investors
88VC1 shared round · last Oct 28, 2021
KKoch Disruptive Technologies1 shared round · last Oct 28, 2021
MMeron Capital1 shared round · last Oct 28, 2021
AAlexandria Venture Investments1 shared round · last Oct 28, 2021
PPiedmont Capital Investments1 shared round · last Oct 28, 2021
TTalos VC1 shared round · last Oct 28, 2021
Similar investors
CCove Hill Partners1 company
SSomersault Ventures2 companies · 1 deal in 12 mo
SSequoia Capital Global Equities4 companies
AAraya Ventures5 companies · 4 deals in 12 moCCervin Ventures5 companies · 3 deals in 12 mo
FFifth Down Capital6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name ICon. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists ICon, which is a subset of its real portfolio. API: /api/v1/investors/icon (get a free API key). More: the most active VC firms and new venture capital funds.